DOUBLE-HIT LEUKEMIA: A VERY HIGH-RISK SUBTYPE PH-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Zicong Huang, 386188

MEASURABLE/MINIMAL RESIDUAL DISEASE (MRD) STATUS IS THE MOST RELEVANT INDICATOR OF CLINICAL OUTCOME IN MIXED PHENOTYPIC ACUTE LEUKEMIAS (MPAL)

EHA Library, Prashant Tembhare, 386189

HIGH REMISSION AND SURVIVAL RATE IN ADULTS WITH MINIMAL RESIDUAL DISEASE-POSITIVE OR RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA TREATED WITH BLINATUMOMAB IN ROUTINE CLINICAL PRACTICE

EHA Library, Sabina Chiaretti, 386190

OUTCOMES IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING HEMATOPOIETIC CELL TRANSPLANTATION USING REAL-WORLD DATA FROM HARMONY

EHA Library, Alexander Russell-Smith, 386191

A PHASE II STUDY OF FLUMATINIB WITH CHEMOTHERAPY FOR NEWLY DIAGNOSED PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS: UPDATED RESULTS FROM RJ-ALL2020.2A TRIAL

EHA Library, Weiyang Liu, 386192

A PHASE II STUDY OF LOW-INTENSITY CHEMOTHERAPY (MINI-HYPER-CVD) AND PONATINIB FOLLOWED BY BLINATUMOMAB AND PONATINIB IN PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Fadi Haddad, 386193

SEQUENTIAL BLINATUMOMAB WITH REDUCED INTENSITY CHEMOTHERAPY FOR OLDER ADULTS WITH NEWLY DIAGNOSED PH- B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA – FINAL RESULTS OF THE ALLG ALL08 STUDY

EHA Library, Shaun Fleming, 386194

ARE MINIMAL RESIDUAL DISEASE MEASUREMENTS AFTER CONSOLIDATION THERAPY USEFUL IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA?

EHA Library, Janine Stutterheim, 386195

LONG-TERM OUTCOMES OF ADULTS WITH RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH BREXUCABTAGENE AUTOLEUCEL IN ZUMA-3 BY AGE, PRIOR THERAPIES, AND SUBSEQUENT TRANSPLANT

EHA Library, Bijal D. Shah, 386196

GENOMIC LANDSCAPE OF PEDIATRIC ACUTE B LYMPHOBLASTIC LEUKEMIA IN CHINA

EHA Library, Yangyang Gao, 386197

DONOR-DERIVED ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T CELLS FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A PHASE 1 TRIAL

EHA Library, Yi Luo, 386198

EFFICACY AND SAFETY OF THE THIRD-GENERATION TKI OLVEREMBATINIB IN ADULTS PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH T315I MUTATION AND RELAPSED/REFRACTORY DISEASE

EHA Library, Weiyang Liu, 386199

PONATINIB AS A PROPHYLACTIC OR PRE-EMPTIVE STRATEGY TO PREVENT CYTOLOGICAL RELAPSE AFTER ALLO-SCT IN PATIENTS WITH PH POS ALL TRANSPLANTED IN COMPLETE CYTOLOGICAL REMISSION

EHA Library, Anna Candoni, 386200

CMV REACTIVATIONS/INFECTIONS IN PH+ ALL PATIENTS TREATED WITH DASATINIB WITH OR WITHOUT BLINATUMOMAB. A RETROSPECTIVE MULTICENTER CAMPUS ALL STUDY

EHA Library, Mario Annunziata, 386201

UPDATES FROM A PHASE II TRIAL OF MINI-HYPER-CVD-INOTUZUMAB WITH OR WITHOUT BLINATUMOMAB IN OLDER PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME (PH)-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Fadi Haddad, 386202

THROMBOTIC EVENTS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA: EXPERIENCE OF ITALIAN AIEOP CENTERS (2009-2017)

EHA Library, Raffaele Mattera, 386203

INOTUZUMB OZOGAMICIN PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPSED OR REFRACTORY ACUTE B-LYMPHOBLASTIC LEUKEMIA

EHA Library, Sabine Kayser, 386204

VENO-OCCLUSIVE DISEASE RISK AND OTHER OUTCOMES IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING INOTUZUMAB OZOGAMICIN AND PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Marcos de Lima, 386205

A PHASE II TRIAL OF MINI-HYPER-CVD WITH VENETOCLAX FOR PATIENTS WITH RELAPSED/REFRACTORY (R/R) PHILADELPHIA CHROMOSOME (PH)-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

EHA Library, Fadi Haddad, 386206

CHEMO-FREE TREATMENT OF VAF INDUCE A EARLY AND DEEP MOLECULAR RESPONSEIN IN PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LEUKEMIA : A PROSPECTIVE, SINGLE ARM, PHASE II STUDY

EHA Library, Xiaowen Tang, 386207

PONATINIB AND BLINATUMOMAB IN RELAPSED/REFRACTORY PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OR CHRONIC MYELOID LEUKEMIA IN LYMPHOID BLAST PHASE: SUBGROUP ANALYSIS FROM A PHASE II TRIAL

EHA Library, Fadi Haddad, 386208

FULL PEDIATRIC INDUCTION IN ADULTS AGED UP TO 55 YEARS WITH PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA IS WELL TOLERATED AND RESULTS IN VERY HIGH CURE RATE

EHA Library, Elena Maio, 386210

A CLINICAL PROGNOSTIC SCORING SYSTEM FOR ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION OUTCOMES IN ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Song Wang, 386211

THE NEXT-GENERATION SEQUENCING (NGS) BASED MRD ASSESSMENT COULD BETTER PREDICT RELAPSE THAN MULTIPARAMETER FLOW CYTOMETRY (MFC) IN ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Nan Yan, 386212

LOW CD19-MFI IN BALL CELLS BEFORE CAR T INFUSION PREDICTED A GOOD RESPONSE AND LONGER MRD-NEGATIVE MAINTENANCE TIME

EHA Library, Ping Wang, 386213

COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE

EHA Library, Maria Agustina Perusini, 386214

COMPARISON OF THE PHARMACOKINETICS OF THE LIQUID AND THE LYOPHILIZED FORMULATIONS OF PEGASPARGASE IN THE TREATMENT OF PEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

EHA Library, Alexander Karachunskiy, 386215

THE TREATMENT RESPONSE OF A TWO-DOSE REGIMEN OF DOSE-ADJUSTED INOTUZUMAB IN RELAPSED/REFRACTORY B-ALL

EHA Library, Shuangyou Liu, 386216

THERAPY OF ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON PEDIATRIC-INSPIRED PROTOCOLS IN THE CZECH REPUBLIC IN 2007–2020

EHA Library, Jan Horacek, 386217

METHOTREXATE NEUROTOXICITY IN ADULT ALL

EHA Library, Andre Khazak, 386218

ALLO-HSCT OR CHEMOTHERAPY FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN THE FIRST COMPLETE REMISSION: IMPACT OF MRD AND IKZF1

EHA Library, Shiyu Deng, 386219

PROGNOSTIC ANALYSIS OF RELAPSED PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA TREATED BY CCLG-ALL2008 PROTOCOL IN CHINA

EHA Library, Ning Wang, 386220

FEATURES AND TREATMENT OF PATIENTS WITH T(8;14)(Q24;Q11) / TCRA/D::MYC TRANSLOCATED T ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA (T-ALL/LBL)

EHA Library, Xian Zhang, 386221

GENETIC CHARACTERISTICS OF PEDIATRIC B-OTHER ACUTE LYMPHOBLASTIC LEUKEMIA COHORT USING TARGETED RNA SEQUENCING

EHA Library, Eliza Głodkowska-Mrówka, 386222

FRONTLINE COMBINATION OF OLVEREMBATINIB AND PDT-ALL-2016 PEDIATRIC INSPIRED PROTOCOL IN PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Kaibo Zhu, 386223

PREDICTING SURVIVAL AFTER HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT T‐CELL ACUTE LYMPHOBLASTIC LEUKAEMIA: DEVELOPMENT AND VALIDATION OF THE SAVED MODEL

EHA Library, Meng-Yu Xiao, 386224

FIFTEEN YEARS OF RUSSIAN RESEARCH IN THE TREATMENT OF ADULT PATIENTS WITH ACUTE PH-NEGATIVE LYMPHOBLASTIC LEUKEMIA ACCORDING TO THE PROTOCOLS ALL-2009 AND ALL-2016.

EHA Library, Olga Aleshina (Gavrilina), 386225

IKZF1 ALTERATIONS HAVE A NEGATIVE IMPACT ON EARLY MOLECULAR RESPONSE AND SURVIVAL OF ADULT PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH GMALL 07/2003 PROTOCOL IN CZECHIA

EHA Library, Vaclava Polivkova, 386226

HIGH-RISK CHILDHOOD AND ADOLESCENT AND YOUNG ADULTS ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH THE EORTC 58951 PROTOCOL: RESULTS AND OUTCOME

EHA Library, Imen Frikha, 386227

SUCCESSFUL IMPLEMENTATION OF A MODIFIED ST JUDE TOTAL XV PROTOCOL FOR TREATING CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA  IN LEBANON. LESSONS FOR LOW- AND MIDDLE-INCOME COUNTRIES.

EHA Library, Lara Ghaddar, 386228

COMPARISON OF MORPHOLOGICAL & MRD RESPONSE WITH DEXAMETHASONE VERSUS PREDNISOLONE IN BFM 2009 INDUCTION THERAPY IN PEDIATRIC AND AYA ACUTE LYMPHOBLASTIC LEUKEMIA: A SINGLE-CENTER STUDY FROM INDIA

EHA Library, karthik kumar, 386229

INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY

EHA Library, suning chen, 386230

INOTUZUMAB OZOGAMICIN TREATMENT IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA CHROMOSOME-NEGATIVE CD22-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REAL-LIFE FRENCH STUDY

EHA Library, Sébastien Maury, 386231

HIGH EXPRESSION OF STAT5 INDICATES POOR PROGNOSIS IN B CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Xiuli Xu, 386232

IMMUNOGLOBULIN GENE REARRANGEMENT IN KOREAN PATIENTS WITH B-LYMPHOBLASTIC LEUKEMIA – AN IMMUNOPHENOTYPE AND REPERTOIRE ANALYSIS

EHA Library, Daehyun Chu, 386233

IN VITRO RESPONSE TO BCL-2 INHIBITION IN PEDIATRIC B PRECURSOR ALL WITH HIGH RISK CYTOGENETICS

EHA Library, Francesca Gottardi, 386234

INCIDENCE OF COMPLICATIONS OF HIGH-DOSE METHOTREXATE ADMINISTRATION IN ADULTS AND CHILDREN WITH HEMATOLOGIC CANCERS: PRELIMINARY RESULTS FROM A EUROPEAN REGISTRY

EHA Library, Scott Howard, 386235

MITOTIC FIDELITY IS A RESISTANCE MECHANISM TO DECITABINE IN MYELOID TUMORS.

EHA Library, Tomohiro Yabushita, 386236

COMBINATORIAL BCL-2 FAMILY EXPRESSION IN ACUTE MYELOID LEUKEMIA STEM CELLS PREDICTS CLINICAL RESPONSE TO AZACITIDINE/VENETOCLAX

EHA Library, Simon Renders, 386237

BCL-2/BCL-XL INHIBITION INDUCES APOPTOSIS AND CIRCUMVENTS VENETOCLAX RESISTANCE IN TP53-MUTATED ACUTE MYELOID LEUKEMIA

EHA Library, Ida Vänttinen, 386238

COMBINING MENIN AND MEK INHIBITION TO TREAT CHILDREN WITH POOR PROGNOSTIC KMT2A-R RAS-MUTANT ACUTE LEUKEMIA

EHA Library, Nastassja Scheidegger, 386239

LONGITUDINAL CHARACTERIZATION OF MOLECULAR VARIANTS AT REMISSION AND RELAPSE: SUBANALYSIS OF THE QUAZAR AML-001 TRIAL

EHA Library, Andrew H. Wei, 386240

TRANSCRIPTOMIC CLASSIFICATION, RISK STRATIFICATION AND THERAPY SELECTION IN AML

EHA Library, Jeppe Severens, 386241

GENOMIC AND TRANSCRIPTOMIC ANALYSES OF NORMAL KARYOTYPE PRIMARY REFRACTORY ACUTE MYELOID LEUKAEMIA REVEAL HIGH INCIDENCE OF WT1 MUTATIONS AND A TRANSCRIPTIONAL SIGNATURE OF SENESCENCE.

EHA Library, Ali Alhawaj, 386242

PATIENT-DERIVED XENOGRAFT MODELS ARE THE LEADING STRATEGY TO IDENTIFY NEW AGENTS FOR PEDIATRIC ACUTE MYELOID LEUKEMIA

EHA Library, Ambra Da Ros, 386243

A COMPLEX INTERPLAY OF INTRA- AND EXTRACELLULAR FACTORS REGULATES THE OUTCOME OF FETAL- AND ADULT-DERIVED MLL-REARRANGED LEUKEMIA

EHA Library, Sudip Ghosh, 386244

DNA METHYLATION-BASED CHARACTERIZATION OF ACUTE MYELOID LEUKEMIA POINTS TOWARDS KDM3B AS A 5Q HAPLOINSUFFICIENCY CANDIDATE

EHA Library, Katherine Kelly, 386245

GENOMIC LANDSCAPE AND PROGNOSIS IN OLDER ACUTE MYELOID LEUKEMIA PATIENTS NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY

EHA Library, Ekaterina Jahn, 386246

DELE1 LOSS AND DYSFUNCTIONAL INTEGRATED STRESS SIGNALING IN TP53 MUTATED AML IS A NOVEL PATHWAY FOR VENETOCLAX RESISTANCE

EHA Library, Andrew Wei, 386247

HARNESSING MIRNA-193B-3P MIMIC AS A POTENT THERAPEUTIC OPTION IN ACUTE MYELOID LEUKEMIA

EHA Library, Hasan Issa, 386248

THE ROLE OF ACETYLCHOLINE IN THE REGULATION OF ACUTE MYELOID LEUKEMIA STEM CELLS

EHA Library, Michelle Buri, 386249

TARGETED DISRUPTION OF HUMAN FLT3 ERADICATES LEUKEMIC STEM CELLS WITHOUT HARMING HEALTHY HEMATOPOIETIC STEM CELLS

EHA Library, Joana LIMA ARAUJO, 386250

TARGETING THE WT1MUT-MIR-193A TRANSCRIPTIONAL AXIS WITH INT-1B3, A NOVEL LIPID NANOPARTICLE-FORMULATED MIR-193A-3P MIMIC IN ACUTE MYELOID LEUKEMIA

EHA Library, Xining Yang, 386251

ACUTE MYELOID LEUKEMIA REPROGRAMS LIPID METABOLISM BY DOWNREGULATING CD36 EXPRESSION IN HEPATOCYTES.

EHA Library, Rebecca Maynard, 386252

LANDSCAPE OF CHROMATIN ACCESSIBILITY IN ACUTE MYELOID LEUKEMIA

EHA Library, Yotaro Ochi, 386253

A MULTIDIMENSIONAL AND SPATIAL ANALYSIS REVEALS DISTINCT IMMUNE PHENOTYPES AND SECONDARY LYMPHOID ORGAN-RESEMBLING STRUCTURES IN THE BONE MARROW OF PEDIATRIC ACUTE MYELOID LEUKEMIA

EHA Library, Joost Koedijk, 386254

HDAC INHIBITORS RESTORE SENSITIVITY TO VENETOCLAX AND NAVITOCLAX IN AML CELLS RESULTING IN THE IRREVERSIBLE DNA DAMAGE

EHA Library, Elmira Khabusheva, 386255

CEBP/Α CONTROLS A CORE DIFFERENTIATION PROGRAM PERTURBED IN HOX-INDUCED LEUKEMIA

EHA Library, Robert Slany, 386256

THE FATTY ACID ELONGASE ELOVL6 IS CRUCIAL FOR HEMATOPOIETIC STEM CELL ENGRAFTMENT AND LEUKEMIA PROPAGATION

EHA Library, Yusuke Kiyoki, 386257

THERAPY-INDUCED SENESCENCE TRIGGERS UPREGULATION OF ANTIGEN PRESENTATION VIA PRC2 INHIBITION AND PROMOTES ANTI-TUMOUR IMMUNITY IN ACUTE MYELOID LEUKAEMIA

EHA Library, Diego Gilioli, 386258

COMBINATORIAL ADAPTOR-MEDIATED TARGETING OF ACUTE MYELOID LEUKEMIA WITH CAR T-CELLS

EHA Library, Laura Volta, 386259

ACTIVATION OF MACROPHAGE STING ENHANCES PHAGOCYTOSIS OF ACUTE MYELOID LEUKAEMIA

EHA Library, Rebecca Maynard, 386260

VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA IN THE HOVON-SAKK-132 TRIAL

EHA Library, Jesse Tettero, 386261

PHARMACOLOGICAL DUAL INHIBITION OF PARP AND TIP60 AS A PROSPECTIVE THERAPEUTIC REGIMEN INDUCES SYNERGISTIC AML CELL DEATH

EHA Library, Tae Ju Park, 386262

MYELODYSPLASIA-RELATED MUTATIONS IN THE NEW ELN CLASSIFICATION: DOES CLONAL SIZE PLAY A ROLE?

EHA Library, Christian Rausch, 386263

NOVEL COMPOUNDS TO TARGET KMT2A-REARRANGED PEDIATRIC ACUTE MYELOID LEUKEMIA

EHA Library, Claudia Tregnago, 386264

CUTTING-EDGE TRANSCRIPTOMICS TO IDENTIFY LEUKEMIA-INTRINSIC AND -EXTRINSIC CORRELATES OF IMMUNE ESCAPE AND POST-TRANSPLANTATION RELAPSE

EHA Library, Pier Edoardo Rovatti, 386265

EFFECTIVE IMMUNOTHERAPY OF PEDIATRIC T(8;21) ACUTE MYELOID LEUKEMIA BY REPURPOSING CD3XCD19 TARGETING BISPECIFIC ANTIBODIES

EHA Library, Noa Wijnen, 386266

INTRACELLULAR CITRATE LEVELS MODULATE ANTI-APOPTOTIC PROTEINS TO ENHANCE VENETOCLAX SENSITIVITY IN ACUTE MYELOID LEUKEMIA STEM CELLS

EHA Library, Aykut Demir, 386267

RNA SEQUESTRATION IN P-BODIES PROMOTES LEUKEMIA ONSET AND PROGRESSION

EHA Library, Ludovica Proietti, 386268

ENHANCER HIJACKING IN COMPLEX-KARYOTYPE AML

EHA Library, Etienne Sollier, 386269

CLINICAL AND MOLECULAR CHARACTERISTICS OF AML PATIENTS WITH AN EXCEPTIONAL RESPONSE TO IVOSIDENIB

EHA Library, Eytan Stein, 386270

DDX41 GERMLINE VARIANTS: POPULATION PREVALENCE, SIGNIFICANCE AND LEUKEMIC EVOLUTION

EHA Library, Sruthi Cheloor Kovilakam, 386271

A POOLED FOCUSED IN VIVO CRISPR-CAS9 SCREENING IN IMMUNOCOMPETENT MICE ALLOWS IDENTIFICATION OF IMMUNE CHECKPOINTS RELEVANT FOR LEUKEMIC STEM CELLS

EHA Library, Chantal Bachmann, 386272

SINGLE CELL RNASEQ UNCOVERING THE ROLE OF A LEUKEMIC DRIVER GENE FUSION CBFΒ::MYH11 IN THE LEUKEMIC–NICHE SIGNALING

EHA Library, Polina Derevyanko, 386273

A SYSTEMS-BASED APPROACH TO UNVEIL DRUG RESISTANCE IN FLT3-ITD AML

EHA Library, Francesca Sacco, 386274

COMPREHENSIVE CHARACTERIZATION OF DIFFERENTIAL GENE EXPRESSION AND ISOFORM USAGE IN SPLICING FACTOR-MUTATED ACUTE MYELOID LEUKEMIA USING LONG-READ SEQUENCING

EHA Library, Klaus Metzeler, 386275

DECIPHERING THE MITOPHAGY RECEPTOR NETWORK IDENTIFIES A CRUCIAL ROLE FOR OPTINEURIN IN ACUTE MYELOID LEUKEMIA

EHA Library, Sebastian Koschade, 386276

PROGNOSTIC SIGNIFICANCE OF MEASURABLE RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN AUTOLOGOUS STEM CELL APHERESIS PRODUCTS OF PATIENTS WITH AML

EHA Library, Jesse Tettero, 386277

PROTEOGENOMIC PROFILING OF DIAGNOSTIC AND RELAPSE SAMPLES IN PEDIATRIC ACUTE MYELOID LEUKEMIA

EHA Library, Tina Glisovic-Aplenc, 386278

ALDH1A AS A THERAPEUTIC TARGET IN ACUTE MYELOID LEUKEMIA

EHA Library, Mehak Shaikh, 386279

GENE FUSIONS AND OTHER GENOMIC EVENTS UNDERLIE VENETOCLAX AND HYPOMETHYLATING AGENT RESISTANCE AND PROVIDE NEW TARGETS IN ACUTE MYELOID LEUKEMIA.

EHA Library, Anna Ferrari, 386280

CD4+ T CELLS REDUCE THE POPULATION OF LEUKEMIC STEM CELLS IN ACUTE MYELOID LEUKEMIA

EHA Library, Noah Schnüriger, 386281

NOVEL INSIGHTS INTO MINIMAL RESIDUAL DISEASE OF ACUTE MYELOID LEUKEMIA USING PRIMARY SAMPLES AND A CLINICALLY RELEVANT PDX MODEL.

EHA Library, Nesrine Aroua, 386282

ACUTE MYELOID LEUKEMIA (AML) WITH IDH1 AND IDH2 MUTATIONS CAN BE EFFECTIVELY RISK STRATIFIED BASED ON THE PRESENCE ADVERSE RISK GENOMIC FEATURES.

EHA Library, Nikhil Patkar, 386283

RUNX1 DIRECTLY BINDS AND REGULATES THE TCF4 PROMOTER

EHA Library, Mylene Gerritsen, 386284

LEUKEMOGENESIS BY AML-SPECIFIC DRIVER MUTATIONS WITHIN DNMT3A, IDH2 AND NPM1

EHA Library, Ecmel Mehmetbeyoglu, 386285

COMPLEX CARYOTYPE IS AN INDEPENDENT RISK FACTOR IN TP53-MUTATED AML

EHA Library, Christian Rausch, 386286

HIPSC DISEASE MODELING TO STUDY LEUKEMIA DEVELOPMENT IN HAX1 VS ELANE ASSOCIATED CONGENITAL NEUTROPENIA

EHA Library, Benjamin Dannenmann, 386287

DISEASE MONITORING OF NPM1-MUTANT (MUT) ACUTE MYELOID LEUKEMIA (AML) USING MEASURABLE RESIDUAL DISEASE (MRD) ASSESSMENTS DURING ORAL AZACITIDINE (ORAL-AZA) TREATMENT (TX): A QUAZAR AML-001 SUBANALYSIS

EHA Library, Gail Roboz, 386288